| pubmed-article:8595191 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8595191 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:8595191 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:8595191 | lifeskim:mentions | umls-concept:C0205145 | lld:lifeskim |
| pubmed-article:8595191 | lifeskim:mentions | umls-concept:C0162757 | lld:lifeskim |
| pubmed-article:8595191 | lifeskim:mentions | umls-concept:C0170657 | lld:lifeskim |
| pubmed-article:8595191 | lifeskim:mentions | umls-concept:C1145667 | lld:lifeskim |
| pubmed-article:8595191 | lifeskim:mentions | umls-concept:C0044170 | lld:lifeskim |
| pubmed-article:8595191 | pubmed:issue | 16 | lld:pubmed |
| pubmed-article:8595191 | pubmed:dateCreated | 1996-4-18 | lld:pubmed |
| pubmed-article:8595191 | pubmed:abstractText | The serotonin (5-HT) agonist m-chlorophenylpiperazine (mCPP) is commonly used as a neuroendocrine challenge agent in humans, and it is well accepted that its mechanism of action involves direct stimulation of postsynaptic 5-HT receptors. In the present work, we demonstrate that mCPP also displays appreciable affinity (IC50 = 230 nM) for 5-HT transporters labeled by [125I]3 beta-(4-iodophenyl)tropan-2 beta-carboxylic acid methyl ester ([125I]RTI-55) in human occipital cortex. These data agree with reports that show mCPP increases extracellular 5-HT in rat brain via a mechanism involving 5-HT transporters. Our results indicate that mCPP may exhibit a presynaptic 5-HT action in man, and studies utilizing mCPP to assess 5-HT receptor sensitivity should be interpreted with caution. | lld:pubmed |
| pubmed-article:8595191 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8595191 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8595191 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8595191 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:8595191 | pubmed:issn | 0959-4965 | lld:pubmed |
| pubmed-article:8595191 | pubmed:author | pubmed-author:MashD CDC | lld:pubmed |
| pubmed-article:8595191 | pubmed:author | pubmed-author:BaumannM HMH | lld:pubmed |
| pubmed-article:8595191 | pubmed:author | pubmed-author:StaleyJ KJK | lld:pubmed |
| pubmed-article:8595191 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8595191 | pubmed:day | 13 | lld:pubmed |
| pubmed-article:8595191 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:8595191 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8595191 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8595191 | pubmed:pagination | 2150-2 | lld:pubmed |
| pubmed-article:8595191 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:meshHeading | pubmed-meshheading:8595191-... | lld:pubmed |
| pubmed-article:8595191 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8595191 | pubmed:articleTitle | The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain. | lld:pubmed |
| pubmed-article:8595191 | pubmed:affiliation | Clinical Psychopharmacology Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA. | lld:pubmed |
| pubmed-article:8595191 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8595191 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8595191 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8595191 | lld:pubmed |
